Development and conduct of allogeneic stem cell transplant and autologous stem cell gene therapy for — Elizabeth Kang (NATIONAL IN
The first part of this project involves the development of conditioning regimens for allogeneic transplantation of patients with primary immunodeficiencies. In 2007 we used busulfan, Campath and low d
| Project title | Development and conduct of allogeneic stem cell transplant and autologous stem cell gene therapy for |
|---|---|
| Project number | 1ZIAAI000989-17 |
| PI name | Elizabeth Kang |
| Institution | NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES |
| Funding mechanism | ZIA |
| Agency | NIAID |
| Award amount | $2.15M |
| Fiscal year | 2023 |
| Abstract | The first part of this project involves the development of conditioning regimens for allogeneic transplantation of patients with primary immunodeficiencies. In 2007 we used busulfan, Campath and low d |
| Key terms | <Actemra><Active Follow-up><Allergy><Allogeneic Transplantation><Allogenic><Antibodies><Assay><Autog |
$799/mo
Try GrantRadar →